Hyperinsulinaemia and increased insulin signalling in prostate tumour cells as a result of androgen deprivation are likely to activate survival pathways downstream of the insulin receptor which have the potential to contribute to progression to castrate resistance; thus, these candidate molecules downstream of insulin receptor signalling may have therapeutic utility in advanced prostate cancer. Here, INS is linked to prostate cancer.